Bit Capital Gmb H Morphic Holding, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 12, 2025	SELL	$21.33 - $59.42 $39,652 - $110,461	-1,859 Closed	0 $0
Q2 2023 Feb 12, 2025	BUY	$34.33 - $62.11 $63,819 - $115,462	1,859 New	1,859 $107 Million
Q1 2023 Feb 12, 2025	SELL	$26.01 - $48.69 $409,943 - $767,403	-15,761 Closed	0 $0
Q4 2022 Feb 12, 2025	BUY	$24.14 - $30.37 $114,592 - $144,166	4,747 Added 43.1%	15,761 $422 Million
Q3 2022 Feb 12, 2025	BUY	$22.23 - $33.37 $244,841 - $367,537	11,014 New	11,014 $312 Million

4.68M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.